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Abstract 
Introduction: In the scenario of maxillary sinus 
surgery for the later practice of implantology, several 
surgical techniques can be used to reconstruct the 
atrophic alveolar ridge, isolated techniques or associated 
with autogenous, allogeneic, xenogenous, and 
alloplastic biomaterials. The autogenous bone graft is 
the only one capable of presenting three important 
biological properties (osteogenesis, osteoinduction, and 
osteoconduction) guaranteeing a self-regenerative 
potential. Platelet concentrates have been proposed as 
regenerative materials in tissue regeneration 
procedures. Among the platelet concentrates proposed 
in the literature, there is FRP that act as autogenous 
platelet aggregates with osteoinductive properties. As 
an example of xenografts, Bio-Oss® stands out, being 
a bovine bone biomaterial. The excellent 
osteoconductive properties of Bio-Oss® lead to 
predictable and efficient bone regeneration, becoming 
an integral part of bone structure and volume. 
Objective: To carry out a brief systematic review of the 
main considerations for the use of fibrin-rich plasma and 
Bio Oss® in bone regeneration for implant dentistry. 
Methods: The survey was conducted from May 2021 to 
July 2021 and developed based on Scopus, PubMed, 
Science Direct, Scielo, and Google Scholar, following the 
rules of Systematic Review-PRISMA. Study quality was 
based on the GRADE instrument and the risk of bias was 
analyzed according to the Cochrane instrument. 
Results: The lack of bone in the alveolar crests has 
been a major problem in functional aesthetic recovery in 
patients who have suffered dentoalveolar trauma, 




maxillary and mandibular pathologies, in addition to 
infections due to the emotional and possibility of 
deformity. In this context, implant dentistry stands out as 
a modern method of oral rehabilitation for totally or 
partially edentulous patients. For this method to develop 
properly, bone integration of the implant into the recipient 
bone tissue must occur. It was documented that the 
combination of biomaterial and FRP significantly improved 
bone regeneration in the peri-implant area. Placing the 
implant with the simultaneous use of the FRP creates a 
good relationship between hard tissue and soft tissue. FRP 
is used as an adjuvant to Bio-Oss® particles for bone 
augmentation in the maxillary sinus. Conclusion: Based 
on literary findings, it was shown that FRP is favorable for 
bone formation processes for dental implants, especially 
when combined with Bio-Oss®. 
Keywords: Implantology. Bone regeneration. Maxillary 
sinus surgery. Fibrin-rich plasma. Bio-Oss®. Biomaterials. 
 
Introduction 
In the scenario of maxillary sinus surgery for the later 
practice of implant dentistry, the maxillary sinus is the 
largest of the paranasal sinuses and its function is to 
contribute to phonation resonance, conditioning the air 
we breathe and aiding in the production of mucus in the 
nasal cavity [1]. It also acts to equalize barometric 
pressures in the nasal cavity, which is covered by a 
membrane called Schneider's membrane. This membrane 
consists of a cylindrical pseudostratified epithelium with 
calciform cells that produce mucus. The importance of 
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fact that these hair cells play a fundamental role in the 
physiology of the maxillary sinus. While the calciform 
cells produce mucus, these cilia generate movements 
that cause this mucus to be directed to the drainage site 
of the maxillary sinus [1,2]. 
When a dental element is lost in the posterior 
region of the maxilla, there is natural reabsorption of the 
alveolar process and, at the same time, pneumatization 
of the maxillary sinus will occur. It will increase its 
volume towards the place where the roots existed and 
this will often make it difficult or impossible to restore 
implants at the site [3]. For this reason, the maxillary 
sinus floor elevation procedure should be performed, or 
short implants when possible. When grafting procedures 
are needed, our focus is often on the type of biomaterial 
to be used and, in fact, the success and predictability of 
our results do not depend only on the biomaterial [3]. 
It is also necessary to consider the type of defect 
to be treated, its morphology. The morphology will 
impact mainly because the defects have different 
vascularization capacities, different osteogenic cell 
recruitment capacities, different graft natural 
stabilization capacities, therefore, we must consider the 
characteristics of the biomaterials that we must employ, 
but also the characteristics of the bed and the bone 
defect that we intend to treat [4]. 
In addition, several surgical techniques can be used 
to reconstruct the atrophic alveolar ridge, isolated 
techniques, or associated with autogenous, allogeneic, 
xenogeneic, and alloplastic biomaterials. The 
autogenous bone graft is the only one capable of 
presenting three important biological properties 
(osteogenesis, osteoinduction, and osteoconduction) 
guaranteeing a self-regenerative potential [3]. As a 
disadvantage to autogenous bone graft, the need for 
second surgical access in the donor area is highlighted, 
resulting in longer surgical time, morbidity, and a 
consequent greater resistance of the patient to the 
proposed treatment [3]. 
In this context, allogeneic, xenogenous, and 
alloplastic bone grafts are an alternative for the 
treatment of bone deficiencies in the jaws, as they avoid 
the need for a second surgical approach. But due to the 
need for processing to eliminate antigenic components, 
these grafts are uniquely osteoconductive with a lower 
bone formation potential compared to the autogenous 
bone graft [5]. In order to increase the bone formation 
potential of these grafts, combinations have been 
proposed to obtain better regenerative conditions 
through volume preservation and induction of cell 
migration differentiation [5-8]. 
Also in this context, in the last 20 years, platelet 
concentrates have been proposed as regenerative 
 
materials in tissue regeneration procedures. Among the 
platelet concentrates proposed in the literature, there are 
PRP and FRP that act as autogenous platelet aggregates 
with osteoinductive properties. These biomaterials, due to 
their low morbidity and possible regenerative potential, 
have been indicated for use in combination with other 
biomaterials or even alone [4,7]. 
Still, as an example of xenografts, Bio-Oss® stands 
out, being a bovine bone biomaterial. The excellent 
osteoconductive properties of Bio-Oss® lead to 
predictable and efficient bone regeneration, becoming an 
integral part of bone structure and volume [6]. The highly 
porous structure of Bio Oss® offers much space for the 
¬formation¬ of the blood vessels (angiogenesis) and the 
deposit of neoformed bone [8]. The microstructure of the 
surface of Bio Oss® supports the 'excellent growth' of 
osteoblasts, which are responsible for 'bone formation [9]. 
Therefore, the present study aimed to carry out a 
brief systematic review of the main considerations for the 
use of fibrin-rich plasma and Bio Oss® in bone 




The rules of the Systematic Review Platform-PRISMA 
(Transparent report of systematic reviews and meta-




The search strategies for this systematic review were 
based on the keywords (MeSH Terms): “Implantology. 
Bone regeneration. Maxillary sinus surgery. Fibrin-rich 
plasma. Bio-Oss®. Biomaterials”. The survey was 
conducted from May 2021 to July 2021 and was developed 
based on Scopus, PubMed, Science Direct, Scielo, and 
Google Scholar. In addition, a combination of the 
keywords with the Booleans "OR", "AND", and the 
operator "NOT" were used to target the scientific articles 
of interest. 
 
Study Quality and Risk of Bias 
The quality of the studies was based on the GRADE 
instrument [11] and the risk of bias was analyzed 
according to the Cochrane instrument [12]. Two 
independent reviewers performed the research and study 
selection. Data extraction was performed by reviewer 1 
and fully reviewed by reviewer 2. A third investigator 
decided on some conflicting points and made the final 
decision to choose the articles.
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Results and Discussion 
A total of 112 articles were found on bone 
regeneration and implantology. Initially, duplication of 
articles was excluded. After this process, the abstracts 
were evaluated and a new exclusion was performed, 
removing the articles that did not address the theme of 
this article. In total, 54 articles were fully evaluated and 
23 were included and evaluated in this study (Figure 1). 
Considering the Cochrane tool for risk of bias, the 
overall assessment in 4 studies with a high risk of bias 
and 2 studies with uncertain risk. The domains that 
presented the highest risk of bias were related to the 
number of participants in each study approached, and 
the uncertain risk was related to the safety and efficacy 
of bone regeneration and implantology. Also, there was 
no funding source in 3 studies and 2 studies did not 
disclose information about the declaration of conflict of 
interest. 
After the complete analysis of the studies that were 
listed to compose this systematic review, it was found 
that the lack of bone in the alveolar crests has been a 
major problem in the functional esthetic recovery in 
patients who suffered dentoalveolar trauma, traumatic 
tooth extractions, congenital tooth absence, maxillary 
and mandibular pathologies, in addition to infections due 
to the emotional and the possibility of deformity and also 
the economic impact they cause on the National Health 
System (NHS) [1,2]. Furthermore, bone loss can also 
occur due to periodontal disease, traumatic surgery or 
even for physiological reasons due to lack of adequate or 
inadequate prosthetic load [3]. Trauma in the face region 
can affect both soft tissue and hard tissue, so these 
injuries can affect the quality of life and health of the 
victim [3].
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Maxillofacial trauma can be considered one of the most 
devastating aggressions found in traumatology and 
oncology due to the emotional consequences and the 
possibility of deformity, as well as the economic impact 
they cause on the Unified Health System (NHS) [4]. The 
face, more than any other region of the body, is affected 
by aesthetic changes as it is always visible and damage 
is immediately noticed. For this reason, facial trauma 
deserves attention in the treatment of multiple trauma 
due to its high incidence and severity [13]. 
In this context, implant dentistry stands out as a 
modern method of oral rehabilitation for totally or 
partially edentulous patients. For this method to develop 
properly, bone integration of the implant into the 
recipient bone tissue must occur, since bone integration 
is the key to clinical surgical success, which will be 
completed after the end of the prosthetic phase [14]. 
Dental implants are being used more and more due to 
the high success rates. However, a large number of 
patients do not have sufficient minimum bone conditions 
for the installation of implants, therefore, previous bone 
reconstructive surgery is necessary. It is essential that 
dentists master the knowledge in the healing process of 
post-extraction alveoli, in order to provide correct 
planning of cases [1]. 
In this context, fibrin-rich plasma (FRP) as an 
autologous biomaterial was developed in France by 
Choukroun et al. (1993) [4] for specific use in oral and 
maxillofacial surgery. This biomaterial has the majority 
of leukocytes, platelets, and growth factors, forming a 
fibrin matrix, with a three-dimensional architecture. It is 
the second generation of platelet concentrate with a 
high potential for wound repair. 
Furthermore, FRP is based on protecting growth 
factors from proteolysis that can maintain their activity 
for a longer period and stimulate bone regeneration 
more efficiently [15]. The most critical phase of the sinus 
membrane elevation procedure after maxillary sinus 
lateral wall osteotomy is its detachment [16]. At this 
stage, Schneider's membrane ruptures may occur, in 
around 15.0% of the cases, which, depending on the 
size of the perforation, may make the graft unfeasible, 
mainly due to the containment character of the graft 
material that the membrane exerts. The most frequent 
causes of these perforations are inadequate 
osteotomies, incomplete membrane detachments with 
lack of bone support for lifting curettes, exerting 
excessive pressure on the membrane, and the presence 
of septa [17-20]. 
If sinus membrane perforations are present, this 
should be quantified [21], as small perforations do not 
require treatment as membrane folds obliterate the 
 
perforation. In the case of ruptures greater than 5.0 mm, 
the use of collagen membranes is indicated [22]. Another 
study indicated the use of fibrin membranes obtained 
from FRP to seal the perforations. In the presence of 
perforations larger than 10.0 mm, the surgery should be 
aborted and re-entry performed after 60 to 90 days [23]. 
The development of optimized implant surfaces is a 
matter of great research with the objective of accelerating 
the osseointegration process, leading to a reduction in the 
waiting time before loading, in addition to making the 
immediate loading of the implant safer [23]. It was 
documented for the first time that the combination of 
biomaterial and FRP significantly improved bone 
regeneration in the peri-implant area. The placement of 
the implant with the simultaneous use of the PRP creates 
a good relationship between the hard tissue and the soft 
tissue, in addition to the advantage of the psychological 
relationship with the patient [24]. 
The most used xenograft in guided bone 
regeneration procedures is deproteinized bovine bone 
mineral, commercially known as Bio-Oss®, it is the most 
researched product in regenerative dentistry worldwide. 
It is a bone of bovine origin processed to produce natural 
bone minerals without organic elements. After thermal 
and chemical treatments, the inorganic phase of bovine 
bone consists mainly of hydroxyapatite (HA) which retains 
the porous architecture. The excellent osteoconductive 
properties of Bio-Oss® lead to predictable and efficient 
bone regeneration, Bio-Oss® particles become an integral 
part of the newly formed bone structure and conserve 
their volume in the long term [9]. Due to its 'great' 
resemblance to the human bone, the Bio Oss® is 
'incorporated' into the 'natural process of 'shaping' and 
'reshaping'. The highly porous structure of the Bio Oss® 
offers a lot of space for the formation of blood vessels 
(angiogenesis) and the deposit of neoformed bone [25]. 
The microstructure of the surface of Bio Oss® helps the 
excellent growth of the osteoblasts which are responsible 
for bone formation [24]. 
Thus, fibrin-rich plasma (FRP) as an autologous 
biomaterial for use in oral and maxillofacial surgery 
presents the majority of leukocytes, platelets, and growth 
factors, forming a fibrin matrix, with a three-dimensional 
architecture. The Bio-Oss® (Geistlich) biomaterial, as it is 
biodegradable, biocompatible, non-toxic, and has low 
immunogenicity and bio stimulators, can act in the 
regeneration of bone tissue, as it establishes with the 
adenomatous mesenchymal stem cells the appropriate 
biological niche for bone growth and, thus, allowing the 
dental implant as effectively as possible [26]. 
Based on this, two important studies reported results 
on the combined use of Bio-Oss® and FRP. Thus, the first  
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study investigated clinically and histologically the 
potential of FRP as a graft material in pre-implant 
reconstructive surgeries for severe maxillary atrophy 
after sinus elevation procedures in 106-120-180 days, to 
determine whether the use of FRP is able to accelerate 
the bone regeneration process, which is essential to 
promote implant stability. This study also includes a 
control group, in which only deproteinized bovine bone 
(Bio-Oss®) was used as reconstructive material. As a 
result, in fact, the use of FRP optimized bone formation 
[8]. 
The second study compared the use of Bio-Oss® 
mixed with FRP and Bio-Oss® with Tisseel® to improve 
bone regeneration. After elevating the sinus membrane 
in both maxillary sinus cavities, an implant was placed 
in the sinus cavity. In one of the sinus cavities, the 
FRP/Bio-Oss® composite was grafted and the Tisseel® 
/ Bio-Oss® composite was grafted in the other sinus 
cavity. After a 6-month healing period, bone formation 
at the graft sites and bone-implant contact were 
assessed. The mean rate of osseointegration was 43.5 
± 12.4% and the rate of new bone formation was 41.8 
± 5.9% at the FRP/Bio-Oss® composite sites. In the 
composite sites, Tisseel® / Bio-Oss® was 30.7 ± 7.9% 
and 31.3 ± 6.4%. There were statistically significant 
differences between groups. The findings of this study 
suggested that when FRP is used as an adjuvant to Bio-
Oss® particles for bone augmentation in the maxillary 
sinus, bone formation at the graft sites is significantly 
greater than when Tisseel® is used [9]. 
For the success of dental implant practice, 
osseointegration is essential. However, it is a complex 
process with many factors interfering in the formation 
and maintenance of bone tissue around the implant, 
such as topography and surface roughness, 
biocompatibility, and loading conditions. In addition, it 
is necessary for a host bone layer that is healthy, 
compatible, and that allows primary stability [22]. 
In this sense, after an extraction, the repair process 
occurs in the inner region of the alveolus, together with 
the formation of a clot rich in cells and growth factors, 
promoting neoformation, bone remodeling, and soft 
tissue epithelialization [21]. During this process, the 
alveolar ridge undergoes relevant changes, both in 
height and in thickness, which influence the possibility 
of installing the implants. Thus, the optimized processes 
of implantology and biomaterials allow the installation of 
implants in areas of thin bone thickness, width, and 
height, with simpler surgeries and greater success rate 
and patient comfort [21]. 
The lack of bone in the alveolar crests has been a 
major problem in functional aesthetic recovery in 
patients who have suffered dentoalveolar trauma, 
 
traumatic tooth extractions, congenital tooth loss, 
maxillary and mandibular pathologies. To fill large bone 
defects, the development of bone regeneration improves 
the epithelial barriers for the bone graft, favoring greater 
predictability in alveolar and peri-implant reconstructions, 
with a good prognosis. In this sense, filling biomaterials 
can be fibrin-rich plasma (FRP), Bio-Oss®, 
hydroxyapatite, lyophilized and ground demineralized 
bone marrow, autogenous bone, which is considered the 
gold standard, among others [21]. 
To improve osseointegration and bone anchorage, 
surface modifications can be chemical, such as calcium 
phosphate (Ca-P) or physical impregnation, being related 
to the microtopography of the implant [24]. Several 
variables affect the biological activity of FRP preparations, 
such as the number of centrifuges used, the centrifugation 
speed, and other protocols that result in preparations with 
multiple volumes, platelet numbers, amount of growth 
factors, and concentration of white blood cells and 
fundamental erythrocytes [22]. 
Some researchers recommend avoiding tissue 
exposure to FRP-containing leukocytes, arguing that an 
inflammatory reaction may occur. On the other hand, 
other authors have described beneficial effects due to 
increased immunological and antibacterial resistance, 
although there is no clinical evidence to support its effect 
[23]. FRP has gained prominence in the scientific 
community for not requiring the addition of an activator 
or anticoagulant, making the product more autologous, 
featuring a fibrin network that protects the growth factors, 
keeping them in place for longer. It also shows other 
forms of application making its use simpler [24]. 
In this sense, the bioactivation of the dental implant 
surface with FRP has been described and discussed by the 
scientific community as a surface treatment for the 
stimulation and acceleration of the osseointegration 
process, as well as to achieve greater primary implant 
stability [23]. The need to rehabilitate edentulous areas 
that have undergone major resorptions is a current need 
and the maxillary sinus elevation maneuver is a viable way 
to implant an anchorage for implant-supported oral 
rehabilitation [1]. One of the relatively frequent 
complications (15.0%) of the procedures is the rupture of 
the sinus membrane during the displacement of the sinus 
membrane. The main complication of this rupture is 
related to the containment of the graft [1]. 
In this context, small perforations with an extension 
of 1.0 to 2.0 mm are contoured with the membrane folds 
in their elevation, but when they reach lengths greater 
than these, the membranes must be added to close the 
same, and larger tears than 10.0 mm. The surgery must 
be aborted and reinserted after a period of re-
epithelialization of the antral cavity, that is, between 60 
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and 90 days [2]. 
Thus, the use of an autologous fibrin membrane, 
obtained by centrifugation of the patient's venous blood, 
without adding anticoagulants, provides a quick and 
efficient repair of surgical wounds. Fibrin gel constitutes 
the first scar matrix of the injured sites [3]. FRP is the 
second generation of fibrin concentrates, succeeding 
FRP that had as a limitation the release of growth factors 
and cytokines in a very short time [4]. 
FRP presents progressive polymerization and the 
incorporation of circulating cytokines increases in the 
fibrin mesh. This configuration implies a longer life for 
these cytokines, as they are released and used only in 
the remodeling of the initial scar matrix. Cytokines are 
thus kept available in situ for a convenient period when 
cells begin to heal the matrix, that is, when they need 
to be stimulated to reconstruct the injured site [5]. 
According to some authors, FRP acts to protect growth 
factors from proteolysis, which, in this way, can maintain 
their activity for a longer period and stimulate tissue 
regeneration. The use of autogenous bone, especially 
the bone induction capacity, has been recommended for 
filling the antral cavity [6]. 
 
Conclusion 
 Based on the literary findings, it became evident 
that FRP is favorable for bone formation processes for 
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